{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:50:06Z","timestamp":1781016606273,"version":"3.54.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K99GM135488"],"award-info":[{"award-number":["K99GM135488"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Computational drug repurposing methods adapt Artificial intelligence (AI) algorithms for the discovery of new applications of approved or investigational drugs. Among the heterogeneous datasets, electronic health records (EHRs) datasets provide rich longitudinal and pathophysiological data that facilitate the generation and validation of drug repurposing. Here, we present an appraisal of recently published research on computational drug repurposing utilizing the EHR. Thirty-three research articles, retrieved from Embase, Medline, Scopus, and Web of Science between January 2000 and January 2022, were included in the final review. Four themes, (1) publication venue, (2) data types and sources, (3) method for data processing and prediction, and (4) targeted disease, validation, and released tools were presented. The review summarized the contribution of EHR used in drug repurposing as well as revealed that the utilization is hindered by the validation, accessibility, and understanding of EHRs. These findings can support researchers in the utilization of medical data resources and the development of computational methods for drug repurposing.<\/jats:p>","DOI":"10.1038\/s41746-022-00617-6","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T10:21:26Z","timestamp":1655202086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Computational drug repurposing based on electronic health records: a scoping review"],"prefix":"10.1038","volume":"5","author":[{"given":"Nansu","family":"Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-8028","authenticated-orcid":false,"given":"Andrew","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9191-3897","authenticated-orcid":false,"given":"Sungrim","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1691-5179","authenticated-orcid":false,"given":"Sunyang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-1185","authenticated-orcid":false,"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-178X","authenticated-orcid":false,"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"617_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/ph11020057","volume":"11","author":"JK Yella","year":"2018","unstructured":"Yella, J. K., Yaddanapudi, S., Wang, Y. & Jegga, A. G. Changing trends in computational drug repositioning. Pharmaceuticals 11, 57 (2018).","journal-title":"Pharmaceuticals"},{"key":"617_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"617_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00213-8","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct. Target. Ther. 5, 1\u201325 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"617_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12793\/tcp.2019.27.3.87","volume":"27","author":"I-J Jang","year":"2019","unstructured":"Jang, I.-J. Artificial intelligence in drug development: clinical pharmacologist perspective. Transl. Clin. Pharmacol. 27, 87 (2019).","journal-title":"Transl. Clin. Pharmacol."},{"key":"617_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cpt.1769","volume":"107","author":"H Xu","year":"2020","unstructured":"Xu, H., Li, J., Jiang, X. & Chen, Q. Electronic health records for drug repurposing: Current status, challenges, and future directions. Clin. Pharmacol. Ther. 107, 712\u2013714 (2020).","journal-title":"Clin. Pharmacol. Ther."},{"key":"617_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/cpt.318","volume":"99","author":"B Chen","year":"2016","unstructured":"Chen, B. & Butte, A. Leveraging big data to transform target selection and drug discovery. Clin. Pharmacol. Ther. 99, 285\u2013297 (2016).","journal-title":"Clin. Pharmacol. Ther."},{"key":"617_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbz147","author":"N Zong","year":"2019","unstructured":"Zong, N. et al. Drug\u2013target prediction utilizing heterogeneous bio-linked network embeddings. Brief. Bioinforma. https:\/\/doi.org\/10.1093\/bib\/bbz147 (2019).","journal-title":"Brief. Bioinforma."},{"key":"617_CR8","doi-asserted-by":"crossref","unstructured":"Zheng, S., Dharssi, S., Wu, M., Li, J. & Lu, Z. Text mining for drug discovery. Methods Mol. Biol. 1939 231\u2013252 (2019).","DOI":"10.1007\/978-1-4939-9089-4_13"},{"key":"617_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/wsbm.1337","volume":"8","author":"RA Hodos","year":"2016","unstructured":"Hodos, R. A., Kidd, B. A., Shameer, K., Readhead, B. P. & Dudley, J. T. In silico methods for drug repurposing and pharmacology. Wiley Interdiscip. Rev. Syst. Biol. Med. 8, 186\u2013210 (2016).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"617_CR10","doi-asserted-by":"crossref","unstructured":"Banerjee, A. G., Khan, M., Higgins, J. & Das, A. K. In 2015 International Conference on Healthcare Informatics. 390\u2013397 (IEEE, 2015).","DOI":"10.1109\/ICHI.2015.55"},{"key":"617_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/cpt.951","volume":"103","author":"JC Denny","year":"2018","unstructured":"Denny, J. C., Van Driest, S. L., Wei, W. Q. & Roden, D. M. The influence of big (clinical) data and genomics on precision medicine and drug development. Clin. Pharmacol. Ther. 103, 409\u2013418 (2018).","journal-title":"Clin. Pharmacol. Ther."},{"key":"617_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41584-019-0337-0","volume":"16","author":"KM Kingsmore","year":"2020","unstructured":"Kingsmore, K. M., Grammer, A. C. & Lipsky, P. E. Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases. Nat. Rev. Rheumatol. 16, 32\u201352 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"617_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.drudis.2011.05.009","volume":"16","author":"L Yao","year":"2011","unstructured":"Yao, L., Zhang, Y., Li, Y., Sanseau, P. & Agarwal, P. Electronic health records: Implications for drug discovery. Drug Discov. Today 16, 594\u2013599 (2011).","journal-title":"Drug Discov. Today"},{"key":"617_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.eswa.2019.01.006","volume":"123","author":"B Davazdahemami","year":"2019","unstructured":"Davazdahemami, B. & Delen, D. The confounding role of common diabetes medications in developing acute renal failure: a data mining approach with emphasis on drug-drug interactions. Expert Syst. Appl. 123, 168\u2013177 (2019).","journal-title":"Expert Syst. Appl."},{"key":"617_CR15","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/clpt.2012.42","volume":"91","author":"D Roden","year":"2012","unstructured":"Roden, D., Xu, H., Denny, J. & Wilke, R. Electronic medical records as a tool in clinical pharmacology: opportunities and challenges. Clin. Pharmacol. Ther. 91, 1083\u20131086 (2012).","journal-title":"Clin. Pharmacol. Ther."},{"key":"617_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.drudis.2017.12.002","volume":"23","author":"G Singh","year":"2018","unstructured":"Singh, G., Schulthess, D., Hughes, N., Vannieuwenhuyse, B. & Kalra, D. Real world big data for clinical research and drug development. Drug Discov. Today 23, 652\u2013660 (2018).","journal-title":"Drug Discov. Today"},{"key":"617_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.phrs.2018.02.013","volume":"130","author":"JA Goldstein","year":"2018","unstructured":"Goldstein, J. A. et al. Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medications. Pharmacol. Res. 130, 44\u201351 (2018).","journal-title":"Pharmacol. Res."},{"key":"617_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/amiajnl-2014-002649","volume":"22","author":"H Xu","year":"2014","unstructured":"Xu, H. et al. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. J. Am. Med. Inform. Assoc. 22, 179\u2013191 (2014).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"617_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.19.00001","volume":"3","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Discovery of noncancer drug effects on survival in electronic health records of patients with cancer: a new paradigm for drug repurposing. JCO Clin. Cancer Inform. 3, 1\u20139 (2019).","journal-title":"JCO Clin. Cancer Inform."},{"key":"617_CR20","doi-asserted-by":"publisher","first-page":"i436","DOI":"10.1093\/bioinformatics\/btaa451","volume":"36","author":"M Zhou","year":"2020","unstructured":"Zhou, M., Zheng, C. & Xu, R. Combining phenome-driven drug-target interaction prediction with patients\u2019 electronic health records-based clinical corroboration toward drug discovery. Bioinformatics 36, i436\u2013i444 (2020).","journal-title":"Bioinformatics"},{"key":"617_CR21","doi-asserted-by":"crossref","unstructured":"Dang, T.-T., Ouankhamchan, P. & Ho, T.-B. In 2016 IEEE RIVF International Conference on Computing & Communication Technologies, Research, Innovation, and Vision for the Future (RIVF) 223\u2013228 (IEEE, 2016).","DOI":"10.1109\/RIVF.2016.7800298"},{"key":"617_CR22","doi-asserted-by":"publisher","first-page":"125ra131","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti, N. P., Patrick, P. Y., Daneshjou, R. & Altman, R. B. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4, 125ra131\u2013125ra131 (2012).","journal-title":"Sci. Transl. Med."},{"key":"617_CR23","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34, D668\u2013D672 (2006).","journal-title":"Nucleic Acids Res."},{"key":"617_CR24","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2015","unstructured":"Kuhn, M., Letunic, I., Jensen, L. J. & Bork, P. The SIDER database of drugs and side effects. Nucleic Acids Res. 44, D1075\u2013D1079 (2015).","journal-title":"Nucleic Acids Res."},{"key":"617_CR25","doi-asserted-by":"publisher","first-page":"D514","DOI":"10.1093\/nar\/gki033","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh, A., Scott, A. F., Amberger, J. S., Bocchini, C. A. & McKusick, V. A. Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33, D514\u2013D517 (2005).","journal-title":"Nucleic Acids Res."},{"key":"617_CR26","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/cpt.1980","volume":"108","author":"DH Kim","year":"2020","unstructured":"Kim, D. H. et al. High\u2010throughput algorithm for discovering new drug indications by utilizing large\u2010scale electronic medical record data. Clin. Pharmacol. Ther. 108, 1299\u20131307 (2020).","journal-title":"Clin. Pharmacol. Ther."},{"key":"617_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep08580","volume":"5","author":"H Paik","year":"2015","unstructured":"Paik, H. et al. Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records. Sci. Rep. 5, 1\u20138 (2015).","journal-title":"Sci. Rep."},{"key":"617_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1089\/adt.2019.950","volume":"17","author":"AP Challa","year":"2019","unstructured":"Challa, A. P. et al. Systematically prioritizing candidates in genome-based drug repurposing. Assay. Drug Dev. Technol. 17, 352\u2013363 (2019).","journal-title":"Assay. Drug Dev. Technol."},{"key":"617_CR29","doi-asserted-by":"crossref","unstructured":"Nordon, G., Koren, G., Shalev, V., Horvitz, E. & Radinsky, K. In Proc. AAAI Conference on Artificial Intelligence (ed. Myers, k.) 9565\u20139572 (AAAI Press, Palo Alto, California USA, 2019).","DOI":"10.1609\/aaai.v33i01.33019565"},{"key":"617_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000000513","volume":"68","author":"L Pinoges","year":"2015","unstructured":"Pinoges, L. et al. Risk factors and mortality associated with resistance to first-line antiretroviral therapy: multicentric cross-sectional and longitudinal analyses. J. Acquir. Immune Defic. Syndr. 68, 527\u2013535 (2015).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"617_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"H Wang","year":"2020","unstructured":"Wang, H., Deng, Y., Wan, L. & Huang, L. A comprehensive map of disease networks and molecular drug discoveries for glaucoma. Sci. Rep. 10, 1\u201313 (2020).","journal-title":"Sci. Rep."},{"key":"617_CR32","doi-asserted-by":"crossref","unstructured":"Ghalwash, M., Li, Y., Zhang, P. & Hu, J. In Proc. 2017 ACM on Conference on Information and Knowledge Management (eds Lim, E.-P. & Winslett, M.) 1837\u20131846 (Association for Computing Machinery, New York, NY, United States, 2017).","DOI":"10.1145\/3132847.3132986"},{"key":"617_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s42256-020-00276-w","volume":"3","author":"R Liu","year":"2021","unstructured":"Liu, R., Wei, L. & Zhang, P. A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. Nat. Mach. Intell. 3, 68\u201375 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"617_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamacardio.2018.2287","volume":"3","author":"T Cai","year":"2018","unstructured":"Cai, T. et al. Association of interleukin 6 receptor variant with cardiovascular disease effects of interleukin 6 receptor blocking therapy: a phenome-wide association study. JAMA Cardiol. 3, 849\u2013857 (2018).","journal-title":"JAMA Cardiol."},{"key":"617_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.celrep.2018.09.031","volume":"25","author":"C Xu","year":"2018","unstructured":"Xu, C. et al. Accurate drug repositioning through non-tissue-specific core signatures from cancer transcriptomes. Cell Rep. 25, 523\u2013535. e525 (2018).","journal-title":"Cell Rep."},{"key":"617_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-02353-5","volume":"11","author":"K Hsieh","year":"2021","unstructured":"Hsieh, K. et al. Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence. Sci. Rep. 11, 1\u201313 (2021).","journal-title":"Sci. Rep."},{"key":"617_CR37","doi-asserted-by":"publisher","first-page":"e00529","DOI":"10.1002\/prp2.529","volume":"7","author":"G Koren","year":"2019","unstructured":"Koren, G., Nordon, G., Radinsky, K. & Shalev, V. Identification of repurposable drugs with beneficial effects on glucose control in type 2 diabetes using machine learning. Pharmacol. Res. Perspect. 7, e00529 (2019).","journal-title":"Pharmacol. Res. Perspect."},{"key":"617_CR38","unstructured":"Kuang, Z. et al. In Computational Methods for Drug Repurposing (ed. Vanhaelen, Q.) Ch. 15 (Springer, 2019)."},{"key":"617_CR39","unstructured":"Kuang, Z. et al. In IJCAI: Proceedings of the Conference. 2521 (NIH Public Access)."},{"key":"617_CR40","doi-asserted-by":"crossref","unstructured":"Kuang, Z. et al. In Proc. 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (eds Krishnapuram, B. & Shah, M.) 491\u2013500 (Association for Computing Machinery, New York, NY, United States, 2016).","DOI":"10.1145\/2939672.2939715"},{"key":"617_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jbi.2015.12.003","volume":"59","author":"D Jang","year":"2016","unstructured":"Jang, D., Lee, S., Lee, J., Kim, K. & Lee, D. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects. J. Biomed. Inform. 59, 248\u2013257 (2016).","journal-title":"J. Biomed. Inform."},{"key":"617_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12911-021-01617-4","volume":"21","author":"Q Wen","year":"2021","unstructured":"Wen, Q., Liu, R. & Zhang, P. Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases. BMC Med. Inform. Decis. Mak. 21, 1\u201311 (2021).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"617_CR43","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4338\/ACI-2016-09-RA-0160","volume":"7","author":"SP Stenner","year":"2016","unstructured":"Stenner, S. P. et al. ePrescribing: reducing costs through in-class therapeutic interchange. Appl. Clin. Inform. 7, 1168 (2016).","journal-title":"Appl. Clin. Inform."},{"key":"617_CR44","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/cpt.2352","volume":"110","author":"MA Malki","year":"2021","unstructured":"Malki, M. A., Dawed, A. Y., Hayward, C., Doney, A. & Pearson, E. R. Utilizing large electronic medical record data sets to identify novel drug\u2013gene interactions for commonly used drugs. Clin. Pharmacol. Ther. 110, 816\u2013825 (2021).","journal-title":"Clin. Pharmacol. Ther."},{"key":"617_CR45","doi-asserted-by":"publisher","first-page":"109957","DOI":"10.1016\/j.celrep.2021.109957","volume":"37","author":"J Bi","year":"2021","unstructured":"Bi, J. et al. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 37, 109957 (2021).","journal-title":"Cell Rep."},{"key":"617_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbrc.2020.11.095","volume":"538","author":"LR Reznikov","year":"2021","unstructured":"Reznikov, L. R. et al. Identification of antiviral antihistamines for COVID-19 repurposing. Biochem. Biophys. Res. Commun. 538, 173\u2013179 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"617_CR47","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/cpt.2376","volume":"110","author":"CA Bejan","year":"2021","unstructured":"Bejan, C. A. et al. DrugWAS: drug\u2010wide association studies for COVID\u201019 drug repurposing. Clin. Pharmacol. Ther. 110, 1537\u20131546 (2021).","journal-title":"Clin. Pharmacol. Ther."},{"key":"617_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/jcph.1023","volume":"58","author":"S Muraki","year":"2018","unstructured":"Muraki, S. et al. Population pharmacodynamic analysis of uric acid\u2013lowering effects of febuxostat based on electronic medical records in two hospitals. J. Clin. Pharmacol. 58, 304\u2013313 (2018).","journal-title":"J. Clin. Pharmacol."},{"key":"617_CR49","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/phar.2618","volume":"41","author":"TH Cummings","year":"2021","unstructured":"Cummings, T. H., Magagnoli, J., Hardin, J. W. & Sutton, S. S. Drug repurposing of dextromethorphan as a cellular target for the management of influenza. Pharmacotherapy 41, 796\u2013803 (2021).","journal-title":"Pharmacotherapy"},{"key":"617_CR50","doi-asserted-by":"crossref","unstructured":"Zhou, M. et al. Drug repurposing for opioid use disorders: integration of computational prediction, clinical corroboration, and mechanism of action analyses. Mol. Psychiatry 26, 5286\u20135296 (2021).","DOI":"10.1038\/s41380-020-01011-y"},{"key":"617_CR51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/jamiaopen\/ooaa048","volume":"3","author":"M Ozery-Flato","year":"2020","unstructured":"Ozery-Flato, M., Goldschmidt, Y., Shaham, O., Ravid, S. & Yanover, C. Framework for identifying drug repurposing candidates from observational healthcare data. JAMIA Open 3, 536\u2013544 (2020).","journal-title":"JAMIA Open"},{"key":"617_CR52","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/jamia\/ocab165","volume":"28","author":"L Bai","year":"2021","unstructured":"Bai, L. et al. Computational drug repositioning of atorvastatin for ulcerative colitis. J. Am. Med. Inform. Assoc. 28, 2325\u20132335 (2021).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"617_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ddr.21689","volume":"81","author":"D Gurwitz","year":"2020","unstructured":"Gurwitz, D. Repurposing current therapeutics for treating COVID\u201019: a vital role of prescription records data mining. Drug Dev. Res. 81, 777\u2013781 (2020).","journal-title":"Drug Dev. Res."},{"key":"617_CR54","doi-asserted-by":"crossref","unstructured":"Varnai, P., Dav\u00e9, A., Farla, K., Nooijen, A. & Petrosova, L. The Evidence REVEAL study: exploring the use of real\u2010world evidence and complex clinical trial design by the European pharmaceutical industry. Clin. Pharmacol. Ther. 110, 1180\u20131189 (2020).","DOI":"10.1002\/cpt.2103"},{"key":"617_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2217\/cer-2019-0162","volume":"9","author":"M Olson","year":"2019","unstructured":"Olson, M. Can real-world evidence save pharma US $1 billion per year? A framework for an integrated evidence generation strategy. J. Comp. Eff. Res. 9, 79\u201382 (2019).","journal-title":"J. Comp. Eff. Res."},{"key":"617_CR56","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.tips.2019.06.003","volume":"40","author":"MD Paranjpe","year":"2019","unstructured":"Paranjpe, M. D., Taubes, A. & Sirota, M. Insights into computational drug repurposing for neurodegenerative disease. Trends Pharmacol. Sci. 40, 565\u2013576 (2019).","journal-title":"Trends Pharmacol. Sci."},{"key":"617_CR57","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1101\/gr.272484.120","volume":"31","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. Multimodal single-cell\/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer\u2019s disease. Genome Res. 31, 1900\u20131912 (2021).","journal-title":"Genome Res."},{"key":"617_CR58","doi-asserted-by":"publisher","first-page":"e3000970","DOI":"10.1371\/journal.pbio.3000970","volume":"18","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biol. 18, e3000970 (2020).","journal-title":"PLoS Biol."},{"key":"617_CR59","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s43587-021-00138-z","volume":"1","author":"J Fang","year":"2021","unstructured":"Fang, J. et al. Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer\u2019s disease. Nat. Aging 1, 1175\u20131188 (2021).","journal-title":"Nat. Aging"},{"key":"617_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13326-018-0192-y","volume":"9","author":"TC Rindflesch","year":"2018","unstructured":"Rindflesch, T. C. et al. Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing. J. Biomed. Semant. 9, 1\u201314 (2018).","journal-title":"J. Biomed. Semant."},{"key":"617_CR61","doi-asserted-by":"publisher","first-page":"103671","DOI":"10.1016\/j.jbi.2020.103671","volume":"115","author":"Y Si","year":"2021","unstructured":"Si, Y. et al. Deep representation learning of patient data from Electronic Health Records (EHR): a systematic review. J. Biomed. Inform. 115, 103671 (2021).","journal-title":"J. Biomed. Inform."},{"key":"617_CR62","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1093\/jamia\/ocy068","volume":"25","author":"C Xiao","year":"2018","unstructured":"Xiao, C., Choi, E. & Sun, J. Opportunities and challenges in developing deep learning models using electronic health records data: a systematic review. J. Am. Med. Inform. Assoc. 25, 1419\u20131428 (2018).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"617_CR63","doi-asserted-by":"crossref","unstructured":"Xie, F. et al. Deep learning for temporal data representation in electronic health records: a systematic review of challenges and methodologies. J. Biomed. Inform. 126, 103980 (2021).","DOI":"10.1016\/j.jbi.2021.103980"},{"key":"617_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jbi.2017.11.011","volume":"77","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Clinical information extraction applications: a literature review. J. Biomed. Inform. 77, 34\u201349 (2018).","journal-title":"J. Biomed. Inform."},{"key":"617_CR65","doi-asserted-by":"publisher","first-page":"e5359","DOI":"10.2196\/medinform.5359","volume":"4","author":"CS Kruse","year":"2016","unstructured":"Kruse, C. S., Goswamy, R., Raval, Y. J. & Marawi, S. Challenges and opportunities of big data in health care: a systematic review. JMIR Med. Inform. 4, e5359 (2016).","journal-title":"JMIR Med. Inform."},{"key":"617_CR66","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/jamiaopen\/ooaa052","volume":"3","author":"VL Tiase","year":"2020","unstructured":"Tiase, V. L. et al. Patient-generated health data and electronic health record integration: a scoping review. JAMIA Open 3, 619\u2013627 (2020).","journal-title":"JAMIA Open"},{"key":"617_CR67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/amiajnl-2013-001935","volume":"21","author":"C Shivade","year":"2014","unstructured":"Shivade, C. et al. A review of approaches to identifying patient phenotype cohorts using electronic health records. J. Am. Med. Inform. Assoc. 21, 221\u2013230 (2014).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"617_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbi.2017.04.010","volume":"70","author":"R Williams","year":"2017","unstructured":"Williams, R., Kontopantelis, E., Buchan, I. & Peek, N. Clinical code set engineering for reusing EHR data for research: a review. J. Biomed. Inform. 70, 1\u201313 (2017).","journal-title":"J. Biomed. Inform."},{"key":"617_CR69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco, A. C. et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med. 169, 467\u2013473 (2018).","journal-title":"Ann. Intern. Med."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-022-00617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-022-00617-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-022-00617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T22:26:10Z","timestamp":1727389570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-022-00617-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1038\/s41746-022-00617-6","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}